NCT04997889

Brief Summary

This study is a preliminary clinical study about safety of artificial salivary containing cumin and ginger extract in 21 healthy volunteers. After the preliminary clinical study, safety of artificial salivary containing cumin and ginger extract in 112 healthy volunteers. The volunteers will be divided into 2 groups which are artificial salivary containing cumin and ginger extract group and commercial artificial salivary.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
112

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Feb 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 3, 2021

Completed
7 days until next milestone

First Posted

Study publicly available on registry

August 10, 2021

Completed
2.5 years until next milestone

Study Start

First participant enrolled

February 15, 2024

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2024

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2024

Completed
Last Updated

February 7, 2024

Status Verified

February 1, 2024

Enrollment Period

5 months

First QC Date

August 3, 2021

Last Update Submit

February 6, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Salivary acid and base value

    Salivary acid and base value (scale 0 (acid) to 14 (base)) using strip test

    6 days

Secondary Outcomes (3)

  • Mucositis

    6 days

  • Adverse event

    6 days

  • Dry mouth status

    6 days

Study Arms (2)

artificial salivary containing cumin and ginger extract

EXPERIMENTAL

The artificial salivary containing cumin and ginger extract will be used 2 g/time (3 times/day) into the mouth for 6 days. Then, the artificial salivary containing cumin and ginger extract will be stopped for 7-10 days. After that, the artificial salivary containing cumin and ginger extract will be used 2 g/time (3 times/day) into the mouth for 3 days.

Combination Product: Artificial salivary containing cumin and ginger extract

Commercial artificial salivary

ACTIVE COMPARATOR

The commercial artificial salivary will be used 2 g/time (3 times/day) into the mouth for 6 days. Then, the commercial artificial salivary will be stopped for 7-10 days. After that, the commercial artificial salivary will be used 2 g/time (3 times/day) into the mouth for 3 days.

Other: Commercial artificial salivary

Interventions

The artificial salivary containing cumin and ginger extract will be used 2 g/time (3 times/day) into the mouth for 6 days. Then, the artificial salivary containing cumin and ginger extract will be stopped for 7-10 days. After that, the artificial salivary containing cumin and ginger extract will be used 2 g/time (3 times/day) into the mouth for 3 days.

artificial salivary containing cumin and ginger extract

The commercial artificial salivary will be used 2 g/time (3 times/day) into the mouth for 6 days. Then, the commercial artificial salivary will be stopped for 7-10 days. After that, the commercial artificial salivary will be used 2 g/time (3 times/day) into the mouth for 3 days.

Commercial artificial salivary

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age more than 18 years
  • World Health Organization Oral Mucositis Grading Scale =0
  • No using artificial salivary or activated salivary medicine more than 2 weeks
  • No cumin, ginger, xylitol, glycerin allergy
  • Have a willingness to participate in the study

You may not qualify if:

  • Uncontrolled disease
  • Dry mouth
  • Salivary gland disease, inflammation, or sialolith
  • Pregnancy or lactation
  • During participated in other study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Pharmacy Practice, Faculty of Pharmaceutical Sciences, Chulalongkorn Unviersity

Bangkok, 10310, Thailand

RECRUITING

MeSH Terms

Interventions

ginger extract

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

August 3, 2021

First Posted

August 10, 2021

Study Start

February 15, 2024

Primary Completion

June 30, 2024

Study Completion

July 31, 2024

Last Updated

February 7, 2024

Record last verified: 2024-02

Locations